Evidence map›Paper›PMID 39000222›Full record

ArticleInternational journal of molecular sciences2024

Anti-Persisters Activity of

Marta Bianchi, Semih Esin, Esingül Kaya, Giovanna Batoni, Giuseppantonio Maisetta

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Proteomic Analysis of the Differential Response ofAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Biotherapeutic potential of different fractions of cell-free supernatants fromFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marta BianchiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy.ORCID 0009-0002-6484-2939
Semih EsinDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy.ORCID 0000-0002-4358-5294
Esingül KayaDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy.
Giovanna BatoniDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy.ORCID 0000-0002-4448-2385
Giuseppantonio MaisettaDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy.ORCID 0000-0001-8043-9029

Funding

The National Recovery and Resilience Plan, part of the Next Gener-ation EU program, PNRR THE-Tuscany Health Ecosystem; and Spoke 7-Innovating Transla-tional Medicine-Sub-project 5-Innovative models for management of infections caused by an-tibiotic-resist ECS00000017
6 · The paper itself

Abstract

Persisters are antibiotic-tolerant bacteria, playing a role in the recalcitrance and relapse of many bacterial infections, including

Indexed as

Anti-Bacterial AgentsBiofilmsLacticaseibacillus rhamnosusMicrobial Sensitivity TestsPseudomonas aeruginosaSputumCulture MediaCulture Media, ConditionedCystic FibrosisHumansPseudomonas InfectionsTobramycinAnti-Bacterial AgentsCulture MediaCulture Media, ConditionedTobramycinantibioticsbiofilmcystic fibrosislactobacilliP. aeruginosapersisters

Identifiers

PMID39000222
PMCPMC11241021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.